CDK4/6 inhibition reprograms the breast cancer immunopeptidome via Rb-dependent chromatin and transcriptomic remodeling
Cell Reports · 2025-12 · 44 (12) · 116676
DOI: 10.1016/j.celrep.2025.116676 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025-12. Verfasst von Robin Minati und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada; Molecular Biology Program, Université de Montré…. Hauptthemen laut MEDLINE: Cyclin-Dependent Kinase 6, Cyclin-Dependent Kinase 4, Retinoblastoma Protein, Breast Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fonds de recherche du Québec, Canadian Breast Cancer Foundation, Quebec Health Research Fund.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada; Molecular Biology Program, Université de Montréal, Montréal, QC H3T 1J4, Canada.
- Institute of Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada.
- Institute of Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada; Department of Medicine, Université de Montréal, Montréal, QC H3T 1J4, Canada. Electronic address: claude.perreault@um…
- Institute of Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada; Department of Chemistry, Université de Montréal, Montréal, QC H3T 1J4, Canada. Electronic address: pierre.thibault@um…
Förderung
- Fonds de recherche du Québec
- Canadian Breast Cancer Foundation
- Quebec Health Research Fund
- Canada Foundation for Innovation
Zitieren
APA
Minati, R., Cahuzac, M., Perrault, J., Lullier, V., Apavaloaei, A., Bonneil, E., Courcelles, M., Lanoix, J., Kina, E., Perreault, C., & Thibault, P. (2025). CDK4/6 inhibition reprograms the breast cancer immunopeptidome via Rb-dependent chromatin and transcriptomic remodeling. Cell Reports, 44(12), 116676. https://doi.org/10.1016/j.celrep.2025.116676
Vancouver
Minati R, Cahuzac M, Perrault J, Lullier V, Apavaloaei A, Bonneil E, et al. CDK4/6 inhibition reprograms the breast cancer immunopeptidome via Rb-dependent chromatin and transcriptomic remodeling. Cell Reports. 2025;44(12):116676. doi:10.1016/j.celrep.2025.116676
BibTeX
@article{Minati2025,
author = {Minati, Robin and Cahuzac, Maxime and Perrault, Julie and Lullier, Véronique and Apavaloaei, Anca and Bonneil, Eric and Courcelles, Mathieu and Lanoix, Joel and Kina, Eralda and Perreault, Claude and Thibault, Pierre},
title = {CDK4/6 inhibition reprograms the breast cancer immunopeptidome via Rb-dependent chromatin and transcriptomic remodeling},
journal = {Cell Reports},
year = {2025},
volume = {44},
number = {12},
pages = {116676},
doi = {10.1016/j.celrep.2025.116676}
}
EUVIMED